Telepsychiatry uses telecommunication technologies to provide psychiatric services remotely. It allows patients in underserved areas to access mental healthcare. A successful telepsychiatry program requires verifying patient identity and location, obtaining informed consent, ensuring private physical environments, coordinating with treatment teams, managing emergencies, using technical guidelines, and addressing challenges like remote locations and patient disabilities. Overall, telepsychiatry increases access to services for patients who otherwise may go without care.
Imran Sarwar Bajwa, [2010], "Virtual Telemedicine Using Natural Language Processing", International Journal of Information Technology and Web Engineering IJITWE 5(1):43-55, January 2010
Presenting on an expert panel on the topic of "eHealth Technologies to leverage patient engagement and compliance" at Health Care Unbound conference, San Diego in July 2010.
Imran Sarwar Bajwa, [2010], "Virtual Telemedicine Using Natural Language Processing", International Journal of Information Technology and Web Engineering IJITWE 5(1):43-55, January 2010
Presenting on an expert panel on the topic of "eHealth Technologies to leverage patient engagement and compliance" at Health Care Unbound conference, San Diego in July 2010.
www.charisma.ro
www.totalsoft.ro
Charisma Medical Software is a modular software solution that integrates and optimizes the processes, the flows, the operational and financial activities specific to hospitals, clinics, pharmacies and medical laboratories. The product offers the possibility of electronic tenders for selecting the suppliers of drugs, instruments, repairs, consumable items or food, while being integrated with HL7 transmission protocol for retrieving and processing data from laboratory analyzers or third party applications.
PAS150 sets unified standards for all rehabilitation services. This presentation examines the existing standards for rehabilitation services, and looks at how PAS 150 works with them and it's application in a clinical perspective.
The radiology department at
Baton Rouge General Medical
Center takes pride in using
advanced technologies to offer
top-notch care to patients and
unparalleled service to referring
physicians.
Based on the recommendations of a committee set up by the Government of India, this document briefly present a set of guidelines of standard practice in Telemedicine in India.
www.charisma.ro
www.totalsoft.ro
Charisma Medical Software is a modular software solution that integrates and optimizes the processes, the flows, the operational and financial activities specific to hospitals, clinics, pharmacies and medical laboratories. The product offers the possibility of electronic tenders for selecting the suppliers of drugs, instruments, repairs, consumable items or food, while being integrated with HL7 transmission protocol for retrieving and processing data from laboratory analyzers or third party applications.
PAS150 sets unified standards for all rehabilitation services. This presentation examines the existing standards for rehabilitation services, and looks at how PAS 150 works with them and it's application in a clinical perspective.
The radiology department at
Baton Rouge General Medical
Center takes pride in using
advanced technologies to offer
top-notch care to patients and
unparalleled service to referring
physicians.
Based on the recommendations of a committee set up by the Government of India, this document briefly present a set of guidelines of standard practice in Telemedicine in India.
Telemedicine in the Healthcare Delivery SystemVSee
For more information of the presentation such as recording and transcript, please visit:
https://goo.gl/yiQNAA
For other webinars:
https://vsee.com/webinars/
Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about
Or Join our Facebook Group:
https://www.facebook.com/groups/tfssgroup/?ref=group_cover
Heavily based on a presentation I gave for the CMS 2020 National Quality Forum. Emphasis is on dialysis (particularly home dialysis). Discusses regulatory framework, medical devices used to render the services and outcomes of studies performed to day
Medical Utopias: The Promise of Emerging TechnologiesAlex Tang
Medical utopias are often about good health, absence of suffering, and even delaying of the aging process. The last two decades have seen a tremendous increase in emerging medical technologies to achieve these utopias. The completion of the sequencing of the human genome sets the stage for the next step of genetic and molecular advances. The increase in computing power, storage capacity, connectivity, and the Internet has opened avenues of new diagnostic and therapeutic modalities. The perfecting of sustaining cell growth in vitro and cell nucleus transfer has opened the way to cloning, stem cell harvesting, and a new field of regenerative medicine. However, these emerging technologies bring with them a large number of bioethical concerns that need to be addressed. These concerns involving tissue engineering, bioelectronics, new genetics, cloning, gene therapy, germ-line genome modifications are only the tip of the iceberg. In this paper I will reflect on three areas of concern. Firstly, the emergence of the digital patient will be considered. This digital patient will be deeply formed and informed by health information technology (IT), the social media, and issues involving privacy, confidentiality and data security. Secondly, the direct to customers (DTC) genetic screening tests will be discussed. The ethical issue of buccal swabs taken at home and be tested for genetic diseases and future prediction of other illnesses which is marketed directly to the consumers will be examined. Finally, the development of new pharmaco-therapeutics will be explored. There have been changes in the way new drugs are tested and these changes do raise some ethical concerns. The examination of these ethical issues will be done in the framework of respect for autonomy, beneficence, non-maleficence, and justice.
Similar to Dr Erin Morrison webinar slides (2) (20)
NIMH i PSC Assays for the Drug Pipeline - Panchisionwef
Dr David Panchision's live presentation at the Schizophrenia Research Forum's live webinar of June 28, 2017 - http://www.schizophreniaforum.org/forums/webinar-modeling-neuropsychiatric-disorders-using-vitro-models
Schizophrenia Research Forum Live Webinar - June 28, 2017 - Rusty Gage wef
Fred Gage's live presentation at the Schizophrenia Research Forum's live webinar of June 28, 2017 - http://www.schizophreniaforum.org/forums/webinar-modeling-neuropsychiatric-disorders-using-vitro-models
SCHIZOPHRENIA RESEARCH FORUM - LIVE WEBINAR June 2017 Kristen Brennandwef
Kristen Brennand presentation at the live webinar of June 28, 2017 hosted by the Schizophrenia Research Forum (http://www.schizophreniaforum.org/forums/webinar-modeling-neuropsychiatric-disorders-using-vitro-models)
STRATEGIES FOR COMMUNICATION AND SENSITIVITY FOR PERSONS EXPERIENCING DEMENTI...wef
Live presentation recorded June 21, 2017, featuring Ellen Phipps and Devin Bowers - review additional material at www.alzpossible.org/strategies-for-communication/
Translating from Animal Models to Human Schizophrenia - Insights into Pathoph...wef
Presentation made by Dr. Tony Grace at the Schizophrenia Research Forum's live webinar of May 4, 2017 - Dopamine in Schizophrenia—Cortical and Subcortical Pathophysiology - review recording of session at http://www.schizophreniaforum.org/forums/dopamine-schizophrenia%E2%80%94cortical-and-subcortical-pathophysiology
Presentation made by Dr. Oliver Howes at the Schizophrenia Research Forum's live webinar of May 4, 2017 - Dopamine in Schizophrenia—Cortical and Subcortical Pathophysiology - review recording of session at http://www.schizophreniaforum.org/forums/dopamine-schizophrenia%E2%80%94cortical-and-subcortical-pathophysiology
Topography and functional significance of the dopaminesgic dysfunction in sch...wef
Presentation made by Dr. Anissa Abi-Dargham at the Schizophrenia Research Forum's live webinar of May 4, 2017 - Dopamine in Schizophrenia—Cortical and Subcortical Pathophysiology - review recording of session at http://www.schizophreniaforum.org/forums/dopamine-schizophrenia%E2%80%94cortical-and-subcortical-pathophysiology
SRF Webinar - What It Will Take to Make Coordinated Specialty Care Available ...wef
Presentation made March 22, 2017, during the live webinar hosted by Schizophrenia Research Forum (SRF). Event recording and additional slides at http://www.schizophreniaforum.org/forums/achieving-effective-treatment-early-psychosis-united-states
SRF Webinar: Beyond DUP - Addressing Disengagement in Community-based Early I...wef
Presentation made March 22, 2017, during the live webinar hosted by Schizophrenia Research Forum (SRF). Event recording and additional slides at http://www.schizophreniaforum.org/forums/achieving-effective-treatment-early-psychosis-united-states
Presentation made March 17, 2017 and hosted by AlzPossible - www.alzpossible.org.
Review recording at http://alzpossible.org/webinars-2/the-basics-memory-loss-dementia-and-alzheimers-disease/
Presentation made at the live webinar hosted by the Schizophrenia Research Forum on the 21st of February, 2017 - http://www.schizophreniaforum.org/forums/treatment-resistant-schizophrenia-new-guidelines-diagnosis-and-terminology
Oliver Howes - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis...wef
Presentation made at the live webinar hosted by the Schizophrenia Research Forum on the 21st of February, 2017 - http://www.schizophreniaforum.org/forums/treatment-resistant-schizophrenia-new-guidelines-diagnosis-and-terminology
John Kane - Treatment-Resistant Schizophrenia: New Guidelines on Diagnosis an...wef
Presentation made at the live webinar hosted by the Schizophrenia Research Forum on the 21st of February, 2017 - http://www.schizophreniaforum.org/forums/treatment-resistant-schizophrenia-new-guidelines-diagnosis-and-terminology
HEAR approach to behavior management Live webinar Feb 1 2017wef
Slides presented at the HEAR Approach to Behavior Management live webinar of February 1, 2017, featuring presentations from Dr. Andrew Heck and Carol Garby.
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
2. What is Telepsychiatry?
Telepsychiatry, also known as e-psychiatry, is the
application of telemedicine to the specialty field
of psychiatry.
Telemedicine is the use
of telecommunication and information technologies in
order to provide clinical health care at a distance.
Tele mental health care is the use of tele-
communications technology to provide mental
health services to individuals in communities or locations
that are underserviced, typically as a result of geographic
isolation.
• Examples: providing health workers in remote areas with continuing education on mental health topics,
videoconferenced consultations on routine and urgent mental health cases using a "virtual" case
management team, and providing direct mental health care services through two-way interactive
systems. One of the most controversial telemental health care applications is providing treatment
services over the Internet directly.
Wikipedia, The Free Encyclopedia
3. Provider and
patient identity
and location
Challenges and Patient
Benefits appropriateness
Elements of
Technical
guidelines
Video-Based Informed
consent
Mental Health
Services1
Emergency Physical
management environment
Collaboration
Medical issues with treatment
team
1American Telemedicine Association
4. Provider + Patient Identity and Location
Verify patient identity and
location
(must verify patient location
for provider state licensure
rules)
Contact information for
Expectations regarding
provider and patient should
contact between sessions
be exchange in case of
should be addressed prior
dropped sessions or for
to the first session
routine questions
1American Telemedicine Association
5. Patient Appropriateness
Situation dependent, but possible in both:
• Home care setting-must consider degree of patient independence
and have more comprehensive emergency plan in place
• Supervised setting- more issues with privacy
Diagnostic considerations-telepsychiatry has been
successfully employed in patients with:
• Psychosis
• Panic disorder
• Cognitive impairment (though may not be appropriate for
unsupervised settings)
“To date, no studies have identified any patient subgroup that does
not benefit from, or is harmed by, mental healthcare provided
through remote videoconferencing.”1
6. Informed Consent
Are there any differences?
Informed consent process is the same as for face to face
care, but must ALSO include (if applicable):
An agreed upon Conditions under which
Process by which
Confidentiality limits in emergency plan telepsychiatry services
patient information will
electronic (patients in settings may be terminated and
be documented and
communication without clinical staff a referral made to face-
stored;
immediately available) to-face care
It is very important to use language the patient can understand when discussing
technical issues (such as data encryption or technical failure of equipment)
7. Physical Environment
Rooms/environments should be comparable to a
standard services room
Ensure privacy so clinical discussion cannot be
overheard
Presence of attendants or family members is situation
dependent and subject to patient consent:
For cognitively impaired patients it is often necessary
for an attendant to be present in the room:
• to assist with orientation
• to tend to audio or visual sensory deficits
• for patient comfort (a familiar caretaker often eases patient anxiety)
8. Communication and Collaboration with
the Patient’s Treatment Team
Essential in the geriatric population
The geriatric patient often has multiple medical problems needing a full
workup (appropriate laboratories, radiologic, and other diagnostic
procedures). This communication can require more effort when one or
more members of the treatment team is located at a remote site, but
can still be accomplished.
Some solutions:
• schedule monthly phone/video treatment team meetings
• ensure all available records for other providers are
available during session
• ensure that the facility (or other providers) have contact
information for the telepsychiatry provider
9. Coordinating Medical Issues-
Who Does What?
Medical
work up
Referrals Ordering or
available for prescription
face to face s/ laboratory
care studies
Follow up of
Management
laboratory or
of medication
radiological
side effects
studies
12. Technical Contingencies
Technology “breakdown”
• Poor/no audio
• Poor/no video
• Dropped sessions
Backup plans
• Discussed with patient before session
• Alternate contact information
Backup plans include calling the patient or facility via telephone and
attempting to troubleshoot the issue. Sessions may be continued by
telephone (situation dependent).
13. Privacy
Recognized encryption standards for
transmission of video & audio
• Federal Information Processing Standard
• Advanced Encryption Standard (AES)
Physical environment (facility limitations)
Appropriate security of medical records
1American Telemedicine Association
14. Challenges
Remote facilities and available internet speed
Patients with sensory impairments - The patient
end would ideally have large monitors, good audio
capabilities, and high bandwidth and video
resolution to make sure there is a large and clear
picture for the elderly
Increased reliance on facility staff, e.g.:
to assist with patients with disabilities,
to give limited physical exams (AIMS test), and
occasionally track down or confirm medication/lab values
15. Overall Benefits - Options!
Choice of providers
Transportation
Scheduling
Bottom Line:
Delivering services to patients who would otherwise go without
16. References
1. Coleman, M., Dennison, O., Drude, K., Goldenson, M., Hirsch, P.,
Kramer, G., … Zucker, M. (2013). Practice Guidelines for Video-
Based Online Mental Health Services-DRAFT. American
Telemedicine Association. Retrieved from
http://www.americantelemed.org/practice/standards/ata-standards-
guidelines
Editor's Notes
Pt refusal of treatment? Cognitively impaired pts , even lucid patients really know what they are agreeing to?